This chemical is primarily used in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds with potential therapeutic applications, such as inhibitors or modulators of biological targets. Its structure, featuring a protected amine group and a carboxylic acid, makes it valuable in peptide and heterocyclic chemistry, enabling the construction of complex molecules. Additionally, it is employed in research settings for the preparation of novel drug candidates, particularly in the fields of neurology and oncology, where oxazepane derivatives are explored for their biological activity.